Schizophrenia Research
Volume 67, Issue 1 , Pages 1-10, 1 March 2004

Mismatch negativity in schizophrenia: a family study

  • Elvira Bramon

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-207-848-5036; fax: +44-207-701-9044.
    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
  • ,
  • Rodney J Croft

      Affiliations

    • Department of Behavioural and Cognitive Sciences, Imperial College School of Medicine, St. Dunstan's Road, London W6 8RF, UK
  • ,
  • Colm McDonald

      Affiliations

    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
  • ,
  • Gurkamal K Virdi

      Affiliations

    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
  • ,
  • John G Gruzelier

      Affiliations

    • Department of Behavioural and Cognitive Sciences, Imperial College School of Medicine, St. Dunstan's Road, London W6 8RF, UK
  • ,
  • Torsten Baldeweg

      Affiliations

    • The Wolfson Centre, University College London and Great Ormond Street Hospital for Sick Children, Mecklenburgh Square, London WC1N 2AP, UK
  • ,
  • Pak C Sham

      Affiliations

    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
  • ,
  • Sophia Frangou

      Affiliations

    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
  • ,
  • Robin M Murray

      Affiliations

    • Institute of Psychiatry, P.O. Box 63, De Crespigny Park, Denmark Hill, London SE5 8AF, UK

Received 9 May 2002; accepted 20 April 2003.

Abstract 

Background: Mismatch negativity (MMN) is a measure of cortical activity that occurs in response to a change in auditory stimuli. We investigated whether MMN is a potential marker of genetic vulnerability to schizophrenia by comparing MMN in a group of patients with schizophrenia, their unaffected relatives, and controls. Method: There are 25 schizophrenic patients, 37 of their unaffected first-degree relatives, and 20 unrelated controls that performed the MMN task. Linear regression with robust standard errors, and accounting for correlations within families, was employed to test for differences in MMN amplitude between the groups. Results: Patients had significantly smaller MMN amplitudes compared to both their unaffected relatives and controls at FZ (P<0.01) and at F3 (P=0.01), whereas relatives and controls did not differ at FZ or at F3. No differences were found between any of the groups at F4. Furthermore, we found no strong evidence that the MMN amplitude is a familial trait. Conclusions: Our results confirm that the MMN amplitude is reduced in schizophrenia. However, the MMN does not show a significant familial influence and is normal among the unaffected relatives. We conclude that while the MMN is abnormal in patients with schizophrenia, it is a weak or unreliable marker of vulnerability when applied to subclinical populations, and therefore is unlikely to be an endophenotype for the disorder.

Keywords:  Mismatch negativity, Schizophrenia, Family study, Genetic vulnerability, Biological marker and endophenotype

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(03)00132-4

doi:10.1016/S0920-9964(03)00132-4

Schizophrenia Research
Volume 67, Issue 1 , Pages 1-10, 1 March 2004